Logo

Resolution Bioscience

Top Five Articles on GenomeWeb Last Week: Agilent, Bruker, Foundation Medicine, More

Last week, GenomeWeb's readers were most interested in Agilent Technologies announcing that it is discontinuing its Resolution Bioscience business.

Agilent Technologies Shuttering Resolution Bioscience Business
Premium

For Q3, the firm said its diagnostics revenues rose 3 percent, but Resolution's kitted NGS-based companion diagnostics business hadn't developed as expected.

Agilent Charges Into Liquid Biopsy Space with Resolution Bioscience Acquisition
Premium

The firm will build liquid biopsy companion diagnostic tests that complement its tissue-based assays and are tailored for drugs developed by pharma partners.

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Under the deal, expected to close in April, Agilent will pay $550 million in cash on closing and up to an additional $145 million based on future milestones.

Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement

The firms will use Resolution's ctDx liquid biopsy technology to find non-small cell lung cancer patients who may benefit from Mirati's KRAS G12C inhibitor therapy.

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Oct 5, 2020

Resolution Bio Seeks to Widen Private Payor Coverage Following Lung Cancer Liquid Biopsy Launch
Premium

Feb 24, 2020

Resolution Bioscience Partnering With LabCorp to Commercialize Lung Cancer Test

Apr 3, 2019

Resolution Bio Liquid Biopsy Outperforms Guardant Test in Lung Cancer Gene Fusion Detection
Premium

Mar 29, 2019

AstraZeneca Liquid Biopsy Comparison Details Concordance Failures
Premium

Jan 25, 2019

Addario Institute, Dana-Farber Partner on Lung Cancer Sequencing Study

Dec 28, 2018

Resolution Bioscience Holds Focus on Liquid Biopsy CDx, Kit Development as it Preps for Growth
Premium

Nov 28, 2018

Advanced Lung Cancer Drivers, Targetable Mutations Identified in Liquid Biopsy Study

Sep 18, 2018

Resolution Bioscience Earns NY State Approval for Lung Cancer Liquid Biopsy Test

Sep 7, 2016

Resolution Bioscience Inks Liquid Biopsy Collaboration With Leidos Biomedical Research

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.